NASDAQ: IONS IONIS PHARMACEUTICALS INC 8-K

Ionis Pharmaceuticals reports Q1 2026 earnings, discloses non-GAAP metrics

Filed April 29, 2026 · Period ending April 29, 2026 · ~1 min read

Key Changes

  • medium

    Ionis announced first quarter 2026 financial results via press release on April 29, 2026. Actual financial figures are contained in the attached press release, not in the 8-K body itself.

  • low

    Company presents non-GAAP results excluding stock-based compensation expense and related tax effects alongside GAAP metrics. Management believes this helps investors assess performance by removing non-cash equity compensation variability.

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (SMID 10-Q) is open in full — no account needed.

Partner

Trade IONS commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 10, 2026 11:57 PM